Acquisition of Nintedanib
About This Opportunity
TranslatedThis tender is for the acquisition of Nintedanib. Nintedanib is a specific pharmaceutical drug, typically used for the treatment of certain types of idiopathic pulmonary fibrosis (IPF) and advanced non-small cell lung cancer (NSCLC). The procurement aims to secure a supply of this medication, likely for a healthcare institution, hospital, or public health program. The tender documents will specify the required dosage forms (e.g., capsules), strengths, quantities, and packaging. Emphasis will be placed on the quality and authenticity of the drug, ensuring it meets all regulatory standards and pharmacopoeial requirements. Bidders are expected to be authorized pharmaceutical suppliers with the capability to provide Nintedanib. The evaluation process will likely focus on the supplier's ability to provide a genuine product, meet delivery schedules, and offer competitive pricing. This acquisition ensures that patients requiring Nintedanib treatment have access to this vital medication.
This is a supplies contract in the health and medical services, information and communication technology and trade and industry sectors, with a focus on Hospitals, Pharmaceuticals, Network Infrastructure and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 26,423.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de Nintedanib" pertains to the procurement of Nintedanib, a medication primarily used in the treatment of idiopathic pulmonary fibrosis and certain types of lung cancer.
This procurement process is situated within the context of public health and aims to ensure the availability of essential pharmaceuticals in Portugal. The contracting authority, while not specified, will likely be a governmental health agency or a hospital network responsible for the procurement of medicines within the national healthcare system.
Typical requirements for this type of tender may include the provision of detailed product specifications, including the formulation, packaging, and shelf life of Nintedanib. Bidders will be expected to demonstrate compliance with pharmaceutical regulations and quality standards, ensuring that the product meets the necessary safety and efficacy criteria established by health authorities. Furthermore, suppliers may be required to provide documentation regarding their manufacturing processes, supply chain logistics, and any certifications that affirm the quality of their products.
The tender process will likely involve a competitive bidding mechanism, emphasizing transparency and equal opportunity for all eligible suppliers. Interested parties should prepare to submit comprehensive proposals that outline their capabilities, pricing structures, and delivery timelines. Given the critical nature of the product being procured, timely and efficient delivery solutions will also be a vital consideration for the contracting authority. This tender reflects Portugal's commitment to maintaining high standards in healthcare provision through the strategic acquisition of pharmaceuticals.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 12, 2026. Last refreshed 5 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Alto Alentejo, EPE
Unidade Local de Saúde do Alto Alentejo, EPE has issued 1,113 procurement notices on BidsFactory, including 2 currently open and 1,034 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Industry & Manufacturing. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to BOERINGER INGLHEIM PORTUGAL. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Alto Alentejo, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €26,423. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.